Benamar Touria, Tajounte Latifa, Alla Amal, Khebba Fatima, Ahmed Hinda, Mulders Mick N, Filali-Maltouf Abdelkarim, El Aouad Rajae
National Institute of Hygiene, Ministry of Health, Rabat, Morocco.
Epidemiology Department, Ministry of Health, Rabat, Morocco.
PLoS One. 2016 Jan 26;11(1):e0147154. doi: 10.1371/journal.pone.0147154. eCollection 2016.
Since the confirmation of measles cases represents an important indicator regarding the performance of the measles-elimination program, the aim of this study was to evaluate the effectiveness of the routine procedures followed in Morocco for the laboratory confirmation of measles cases. Suspected cases reported between January 2010 and December 2012 were assessed for the timeliness of the sample collection, occurrence of measles clinical symptoms, and the results of the laboratory diagnoses. For 88% of the 2,708 suspected cases, a clinical specimen was collected within 7d of rash onset, of which 50% were IgM-positive and 2.6% were equivocal. The measles symptoms were reported in 91.4% of the cases; the occurrence of symptoms showed a positive association with the serological results (odds ratio [OR] = 2.9883, 95% confidence interval [CI] 2.2238-4.0157). Of the negative samples, 52% (n = 116) tested positive by real-time polymerase chain reaction (PCR). These results are in favor of using molecular detection to complement serological diagnosis in the context of measles surveillance approach in Morocco. In addition, the introduction of additional laboratory methods for differential diagnosis is required for the final classification of suspected cases with maculopapular rash and fever in the context of the measles elimination program.
由于麻疹病例的确诊是衡量麻疹消除计划执行情况的一项重要指标,本研究旨在评估摩洛哥用于麻疹病例实验室确诊的常规程序的有效性。对2010年1月至2012年12月期间报告的疑似病例,评估样本采集的及时性、麻疹临床症状的出现情况以及实验室诊断结果。在2708例疑似病例中,88%在出疹后7天内采集了临床标本,其中50% IgM呈阳性,2.6%结果不明确。91.4%的病例报告有麻疹症状;症状的出现与血清学结果呈正相关(优势比[OR]=2.9883,95%置信区间[CI] 2.2238 - 4.0157)。在阴性样本中,52%(n = 116)通过实时聚合酶链反应(PCR)检测呈阳性。这些结果支持在摩洛哥的麻疹监测方法中使用分子检测来补充血清学诊断。此外,在麻疹消除计划背景下,对于有斑丘疹和发热的疑似病例的最终分类,需要引入额外的实验室鉴别诊断方法。